GPS is a sexual health promotion and HIV prevention peer-delivered counselling program. The GPS program has 4 parts: information provision about HIV and sexually transmitted infections, motivational interviewing counselling, sexual health behavioural skills building, and linkage to care. The adaptation grant has three goals: 1) to establish a multi-region and multi-sectoral team that can deliver the revised program across a variety of settings, 2) to learn how best to deliver this program as individual counselling program and also how to adapt this program for HIV-negative MSM, and 3) to pilot the individual program in 5 settings across Ontario and British Columbia. The research team will evaluate the pilot adaptation through mixed methods, employing a quantitative questionnaire and one-on-one semi-structured interviews.
Study Type
INTERVENTIONAL
Allocation
NA
Purpose
PREVENTION
Masking
NONE
Enrollment
50
GPS is a sexual health promotion and HIV prevention program. It has 4 components: provision of information on HIV and sexually transmitted infections, motivational interviewing counselling, sexual health behavioural skills building, and linkage to care in the local community (e.g., referrals to medical, social service, social, mental health, and substance use programs). Among HIV-positive men who have sex with men (MSM) GPS is associated with positive health outcomes including decreased likelihood of condomless anal sex (CAS), particularly CAS with serodiscordant partners. GPS is also associated with decreased fear of being rejected for insisting on condom use and increased condom use self-efficacy.
Health Initiative for Men
Vancouver, British Columbia, Canada
Regional HIV/AIDS Connection
London, Ontario, Canada
Immunodeficiency Clinic - The Ottawa Hospital
Ottawa, Ontario, Canada
Gay ZONE (Centretown Community Health Centre)
Ottawa, Ontario, Canada
MAX Ottawa
Ottawa, Ontario, Canada
AIDS Committee of Toronto
Toronto, Ontario, Canada
Change in the number of serodiscordant condomless anal sex acts
Participants will be asked to report the number of times they engaged in anal sex in the without a condom with a partner of opposite or unknown HIV status in the past two months as part of a self-report questionnaire. This self-report questionnaire is administered at baseline, post-treatment (which is approximately 6 weeks after baseline), and at 3-month follow-up in order to measure changes over time.
Time frame: Past 2 months (measured at baseline, post-treatment, and 3-month follow-up)
Change in the number of sexual partners
Participants will be asked to report the number of sexual partners they had who are HIV-positive, HIV-negative, and of unknown HIV status in the past two months as part of a self-report questionnaire. This self-report questionnaire is administered at baseline, post-treatment (which is approximately 6 weeks after baseline), and at 3-month follow-up in order to measure changes over time.
Time frame: Past 2 months (measured at baseline, post-treatment, and 3-month follow-up)
Change in the number of receptive condomless anal sex acts
Participants will be asked to report the number of times they engaged in receptive anal sex without a condom in the past two months as part of a self-report questionnaire. This self-report questionnaire is administered at baseline, post-treatment (which is approximately 6 weeks after baseline), and at 3-month follow-up in order to measure changes over time.
Time frame: Past 2 months (measured at baseline, post-treatment, and 3-month follow-up)
Change in the number of insertive condomless anal sex acts
Participants will be asked to report the number of times they engaged in insertive anal sex without a condom in the past two months as part of a self-report questionnaire. This self-report questionnaire is administered at baseline, post-treatment (which is approximately 6 weeks after baseline), and at 3-month follow-up in order to measure changes over time.
Time frame: Past 2 months (measured at baseline, post-treatment, and 3-month follow-up)
Change in HIV viral load status
HIV-positive participants will be asked to report whether they had a detectable or undetectable HIV viral load at their last viral load test as part of a self-report questionnaire. This self-report questionnaire is administered at baseline, post-treatment (which is approximately 6 weeks after baseline), and at 3-month follow-up in order to measure changes over time.
Time frame: Most recent viral load test (asked at baseline, post-treatment, and 3-month follow-up)
Change in use of HIV pre-exposure prophylaxis (PrEP)
For HIV-negative participants, participants will be asked whether they use HIV PrEP as part of a self-report questionnaire. This self-report questionnaire is administered at baseline, post-treatment (which is approximately 6 weeks after baseline), and at 3-month follow-up in order to measure changes over time.
Time frame: Present use (asked at baseline, post-treatment, and 3-month follow-up)
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.